Death risk in COVID-19 3.5 times higher than in flu

In a new study, researchers found that the risk of death from COVID-19 was 3.5 times higher than from influenza. They found patients admitted to...

COVID-19 vaccinations: What you need to know about the second dose

In Canada, currently approved COVID-19 vaccines—from Moderna and Pfizer-BioNTech—have demonstrated remarkable efficacy based on two doses taken at specified intervals. But what happens if you...

This study shows the leading risk factor for COVID-19 hospitalization

In a recent study from Geisinger, researchers found that chronic kidney disease is the leading risk factor for hospitalization from COVID-19. The study is published...

At least 50% of COVID-19 infections come from people with no symptoms

In a new study, researchers found that during the initial wave of the COVID-19 outbreak in New York City, only 1 in 5 to...

COVID-19 is a ‘stress test’ for the heart

As we continue to learn more about COVID-19, caused by the novel coronavirus SARS-CoV-2, it is not yet clear all the ways the disease...

One dose of vaccine may be enough for COVID-19 survivors

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those previously...

Humidity from masks may reduce severity of COVID-19

Masks help protect the people wearing them from getting or spreading SARS-CoV-2, the virus that causes COVID-19. In a new study, researchers found evidence for...

This study shows the biggest risk factors for COVID-19 death

In a recent study at the University of Maryland, researchers found that hospitalized COVID-19 patients have a greater risk of dying if they are men...

People with this health problem should get COVID-19 vaccine first

In a new statement, researchers found that COVID-19 vaccine prioritization should prioritize those with advanced heart disease. They suggest that all heart patients face a...

These blood thinning drugs may lower death risk in COVID-19 patients

In a new study, researchers found that patients given preventive blood-thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital with COVID-19 are...